Amyris (AMRS) Reports Q1 Loss of $0.52

Amyris (NASDAQ: AMRS) reported Q1 EPS of ($0.52), versus ($1.97) reported last year. Revenue for the quarter came in at $23 million, versus $13 million reported last year.

“We continue to execute well on our business plan and to lead the industry in growing our top line revenue while significantly expanding our gross margin,” said John Melo, Amyris President & CEO. “We are on track for another record year and continue to perform extremely well in both our consumer and our ingredient businesses. Biossance, our Clean Beauty brand, grew at over 400% in the first quarter and we expect to continue performing well as one of the fastest growing skin care brands in the U.S., also available now in Brazil and Canada.”

For earnings history and earnings-related data on Amyris (AMRS) click here.

You May Also Be Interested In

• SLM (SLM) Tops Q1 EPS by 20c; offers guidance
• FS Bancorp (FSBW) Tops Q1 EPS by 8c
• VIST Financial Corp. (VIST) Misses Q1 EPS by 19c